Literature DB >> 1483696

The intron 7 donor splice site transition: a second Tay-Sachs disease mutation in French Canada.

P Hechtman1, B Boulay, M De Braekeleer, E Andermann, S Melançon, J Larochelle, C Prevost, F Kaplan.   

Abstract

Mutations at the hexosaminidase A (HEXA) gene which cause Tay-Sachs disease (TSD) have elevated frequency in the Ashkenazi Jewish and French-Canadian populations. We report a novel TSD allele in the French-Canadian population associated with the infantile form of the disease. The mutation, a G-->A transition at the +1 position of intron 7, abolishes the donor splice site. Cultured human fibroblasts from a compound heterozygote for this transition (and for a deletion mutation) produce no detectable HEXA mRNA. The intron 7 + 1 mutation occurs in the base adjacent to the site of the adult-onset TSD mutation (G805A). In both mutations a restriction site for the endonuclease EcoRII is abolished. Unambiguous diagnosis, therefore, requires allele-specific oligonucleotide hybridization to distinguish between these two mutant alleles. The intron 7 + 1 mutation has been detected in three unrelated families. Obligate heterozygotes for the intron 7 + 1 mutation were born in the Saguenay-Lac-St-Jean region of Quebec. The most recent ancestors common to obligate carriers of this mutation were from the Charlevoix region of the province of Quebec. This mutation thus has a different geographic centre of diffusion and is probably less common than the exon 1 deletion TSD mutation in French Canadians. Neither mutation has been detected in France, the ancestral homeland of French Canada.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483696     DOI: 10.1007/bf00220467

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  21 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  Distribution of three alpha-chain beta-hexosaminidase A mutations among Tay-Sachs carriers.

Authors:  E E Grebner; J Tomczak
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

3.  Screening for carriers of Tay-Sachs disease among Ashkenazi Jews. A comparison of DNA-based and enzyme-based tests.

Authors:  B L Triggs-Raine; A S Feigenbaum; M Natowicz; M A Skomorowski; S M Schuster; J T Clarke; D J Mahuran; E H Kolodny; R A Gravel
Journal:  N Engl J Med       Date:  1990-07-05       Impact factor: 91.245

4.  Preparation of crude cell extract suitable for amplification of RNA by the polymerase chain reaction.

Authors:  F Ferre; F Garduno
Journal:  Nucleic Acids Res       Date:  1989-03-11       Impact factor: 16.971

5.  More than one mutant allele causes infantile Tay-Sachs disease in French-Canadians.

Authors:  P Hechtman; F Kaplan; J Bayleran; B Boulay; E Andermann; M de Braekeleer; S Melançon; M Lambert; M Potier; R Gagné
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

6.  Ashkenazi-Jewish and non-Jewish adult GM2 gangliosidosis patients share a common genetic defect.

Authors:  R Navon; E H Kolodny; H Mitsumoto; G H Thomas; R L Proia
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

7.  A splicing defect due to an exon-intron junctional mutation results in abnormal beta-hexosaminidase alpha chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease.

Authors:  K Ohno; K Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1988-05-31       Impact factor: 3.575

8.  Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase.

Authors:  B H Paw; M M Kaback; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  Allele-specific amplification of genomic DNA for detection of deletion mutations: identification of a French-Canadian Tay-Sachs mutation.

Authors:  F Kaplan; B Boulay; J Bayleran; P Hechtman
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

10.  Sequence of DNA flanking the exons of the HEXA gene, and identification of mutations in Tay-Sachs disease.

Authors:  B L Triggs-Raine; B R Akerman; J T Clarke; R A Gravel
Journal:  Am J Hum Genet       Date:  1991-11       Impact factor: 11.025

View more
  4 in total

1.  Heterozygosity for Tay-Sachs disease in non-Jewish Americans with ancestry from Ireland or Great Britain.

Authors:  M van Bael; M R Natowicz; J Tomczak; E E Grebner; E M Prence
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

2.  Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs carriers of French Canadian background living in New England.

Authors:  B Triggs-Raine; M Richard; N Wasel; E M Prence; M R Natowicz
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

3.  Multiple mutations are responsible for the high frequency of metachromatic leukodystrophy in a small geographic area.

Authors:  U Heinisch; J Zlotogora; S Kafert; V Gieselmann
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

4.  Identification of novel mutations in HEXA gene in children affected with Tay Sachs disease from India.

Authors:  Mehul Mistri; Parag M Tamhankar; Frenny Sheth; Daksha Sanghavi; Pratima Kondurkar; Swapnil Patil; Susan Idicula-Thomas; Sarita Gupta; Jayesh Sheth
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.